Introduction
Cell line studies
Tumor | Interactions | Cell line | Function | References |
---|---|---|---|---|
Acute leukemia | PTEN | HL-60 cell line and 293T cells | ↑↑ PTENP1: ↑ PTEN mRNA level without affecting PTEN protein levels and cell growth | [10] |
Bladder cancer | miR-17/PTEN axis | EJ, J82, HEK 293 A | ↑↑ PTENP1: ↓ proliferation, migration, invasion, colony formation, ↑ apoptosis | [11] |
miR-20a/PDCD4 axis | Human bladder cancer cell lines J82 and T24, SV-HUC-1 | ↑↑ miR-20a (a target of PTENP1): ↑ proliferation and migration | [12] | |
Breast cancer | miR-20a/PTEN axis, PI3K/Akt signaling | MDA-MB-231, T-47D and MCF-7 , mammary epithelium MCF-10 A | ↑↑ PTENP1: ↓ proliferation, migration, invasion, colony formation, viability | [13] |
miR-19b/ PTEN axis, p53 and p-AKT | MCF-10 A,BT-20, MCF-7, MDA-MB-231 and T-47D | ↑↑ PTENP1: ↓ proliferation, migration, invasion, ↑ apoptosis ↑ p53 and ↓p-AKT | [14] | |
AKT and MAPK signaling pathways | MCF7, 293T | ↑↑ PTENP1: ↓ proliferation, migration, colony formation, cyclin A2 and CDK2, AKT and MAPK signaling pathways | [15] | |
miR-19b/ PTEN axis and PI3K/Akt Pathway | MCF10A, MCF-7 and MDA-MB-231 | ↑↑ PTENP1: ↓ proliferation, migration, invasion, colony formation, PDK-1, p-PI3K, PI3K, and p-Akt, ↑ apoptosis, PTEN | [16] | |
Cervical cancer | miR-106b/ PTEN axis | HeLa, SiHa, C33A, CasKi, H8 | ↑↑ PTENP1: ↓ proliferation, EMT process, ↑ apoptosis | [17] |
miR-27a-3p/ EGR1 axis | C33A, HeLa, ME-180, SiHa, NC104 | ↑↑ PTENP1: ↓ proliferation, EMT process, motility, ↑ apoptosis | [18] | |
miR-19b/ MTUS1 axis | Human normal cervical epithelium cell (HCvEpC) and human CC cell lines, such as Caski, C33A, SiHa and HeLa cells | ↑↑ PTENP1: ↓ proliferation and invasion | [19] | |
Endometrioid endometrial carcinoma | miR-200c/ PTEN axis and PI3K-AKT pathway | RL-952, Ishikawa, HEC-1B, and JEC | 17β-estradiol (E2) treatment: ↑ proliferation, migration and invasion, miR-200c levels, phospho-PI3K-AKT pathway genes and ↓ PTEN level ∆ ERα: ↓ effects of E2 on miR-200c and PTEN | [20] |
Esophageal carcinoma | miR-17‐5p/ SOCS6 axis, p‐STAT3‐HIF‐1α signal pathway | Eca109, TE-1, HEK‐293T, Het‐1 A | ↑↑ PTENP1: ↓ proliferation, vitality, p-STAT3‐HIF‐1α signal pathway | [21] |
Gastric cancer | miR-106b, miR-93 and PTEN | GES-1, gastric adenocarcinoma cell line AGS, SGC7901, MGC803 and BGC823 | ↑↑ PTENP1: ↓ cell growth, migration, and invasion, ↑ apoptosis | [22] |
Glioma | p21 and p38 signaling pathway. | SHG44 and U251 human glioma cells | ↑↑ PTENP1: ↓ proliferation, migration, and invasion, p38 MAPK signaling pathway, ↑ cell cycle arrest, p21 levels | [23] |
miR-10a-5p/ PTEN axis | Glioma cell line U87 | Co-Culture of hUC-MSCs-derived exosomes suppress the proliferation and stimulate the apoptosis of U87 Cells. Exosomes-Mediated Transfer of LncRNA PTENP1 suppresses Cell Growth by Targeting MiR-10a-5p. | [24] | |
Head and neck squamous cell carcinoma | PTEN | WSU-HN4, HN6, HN13, HN30 and Cal27 | ↑↑ PTENP1: ↓ cell growth, migration, invasion, colony formation | [25] |
Hepatocellular carcinoma | miR-21, TET1/2/3, PTEN | SNU-449, HepG2, Hep3B, Huh7 | ↑↑ miR-21: ↑ proliferation, invasion, ↓ apoptosis, expression of TET1/2/3, change in methylation and expression of PTENp1, ↓ PTENp1 and PTEN | [26] |
miR-193a-3p/ PTEN axis | Sk-Hep-1 and SMMC-7721 | ↑↑ PTENP1: ↓ proliferation, migration, invasion, ↑ apoptosis | [27] | |
miR-17, miR-19b and miR-20a, PTEN, PHLPP, ULK1, ATG7 and p62, ↓ PI3K/AKT pathway | human hepatocytes (HH) and HCC cell line Mahlavu | ↑↑ PTENP1: ↓ proliferation, migration, invasion ↑ autophagy and apoptosis | [28] | |
Multiple myeloma | miR-19b/ TSC1 axis | OPM2 and KMS-11 cells | ↑↑ PTENP1: ↓ miR-19b levels and ↑ proliferation | [29] |
Oral squamous cell carcinoma | miR-21/ PTEN, AKT pathways | SCC-25, Cal-27, and HEK 293 cells and ca-8113, | ↑↑ PTENP1: ↓ proliferation, ↑ cell cycle arrest | [30] |
Renal cell carcinoma | miR21/ PTEN axis | Human renal cell carcinoma cell lines 786-O, ACHN, SN12PM6 and HK-2 | ↑↑ PTENP1: ↓ proliferation and cell growth, migration, invasion, metastasis, and ↑ sensitivity of ccRCC cells to cisplatin and gemcitabine | [31] |
Disorders | Interaction | Cell line | Function | References |
---|---|---|---|---|
Alcohol-induced osteopenia | PTEN and Akt/GSK3β/β-catenin signaling | Human BMSCs (hBMSCs) | Ethanol treatment: ↑ PTEN and PTENP1 levels and ↓ Akt/GSK3β/β-catenin signaling ∆ PTEN: ↓ ethanol-induced suppression of bone formation and antiosteogenic effect of ethanol | [32] |
Insulin resistance | miR-499-5p/ PTEN axis | Murine liver cell line NCTC1469 | ↑↑ PTEN: ↓ Akt/GSK activation and glycogen synthesis | [33] |
Osteoporosis | miR-214/ PTEN axis, 3 K/AKT/NF-kB signaling pathway | RAW 264.7 macrophages | ↑↑ PTENP1: ↓ ANKL- induced osteoclast differentiation BY inhibiting 3 K/AKT/NF-kB signaling pathway | [34] |
Sepsis-associated cardiac dysfunction | miR-106b-5p | H9C2 | Matrine administration: ↓ expression of PTENP1 and inflammation, ↑ H9C2 viability | [35] |
Spinal cord injury | miR-21, miR-19b and PTEN | SH-SY5Y and U251 cells | ∆ PTENP1: ↑ apoptosis, miR-21, miR-19b and ↓ cell viability | [36] |
Animal studies
Tumor/ disease type | Animal models | Results | References |
---|---|---|---|
Bladder cancer | 5 week-old male nude mice injected with EJ cell lines | ↑↑ PTENP1: ↓ tumor weight, tumor volume and tumor size | [11] |
Esophageal carcinoma | 4 week-old male nude mice injected with Eca109 cells transfected with PTENP1 3′UTR or NC | ↑↑ PTENP1: ↓ tumorigenesis | [21] |
Head and neck squamous cell carcinoma | 4-week-old male nude mice | ↑↑ PTENP1: ↓ tumorigenesis | [25] |
Hepatocellular carcinoma | 4 week-old BALB/c nude mouse | ∆ miR-21: ↓ tumor growth and size, ↑ PTEN, PTENp1, TET1, TET2 and TET3 | [26] |
4 week-old male immune-deficient nude mice (BALB/c-nu) | ↑↑ PTENP1: ↓ tumor weight and tumor volume | [27] | |
6-8-weeks-old BALB/c nude mic were injected with Mahlavu cells | ↑↑ PTENP1: ↓ tumor growth, intratumoral cell proliferation, and angiogenesis, ↑ apoptosis, autophagy | [28] | |
Oral squamous cell carcinoma | 5 -week-old female BALB/C nude mice mice were injected with Tca-8113 cells transfected with LV-miR-21 plus LV-PTEN and LV-PTENp1 | ↑↑ PTENP1: ↓ tumorigenesis | [30] |
Renal cell carcinoma | Nude mice were injected with ACHN cells transfected with vector control or PTENP1 | ↑↑ PTENP1: ↑ sensitivity of ccRCC cells to cisplatin and gemcitabine | [31] |
Alcohol-induced osteopenia | 40 8-week-old male specific SPF and SD rats | ∆ PTEN: ↓ ethanol-induced osteopenia | [32] |
Insulin resistance | 5 db/db mice and 5 age-matched wild-type (WT) mice | ↑↑ PTENP1: ↑ hepatic insulin resistance | [33] |
Osteoporosis | 8-week-old female C57BL/6 mice | Levels of PTENP1 and PTEN were down-regulated in CS-F- and RANKL-induced bone marrow mononuclear cell. | [34] |
Spinal cord injury | Rats in sham group and SCI, SCI + exosomes, and SCI + exosomes + PTENP1-shRNA groups | Treatment with exosomes + PTENP1-shRNA: ↓ PTEN expression PTENP1 participates in the recovery of SCI through regulation of miR-19b and miR-21. | [36] |
Clinical studies
Tumor/ disease type | Numbers of clinical samples | Expression (Tumor vs. normal) | Kaplan-Meier analysis | Polymorphism in PTENP1 associated with Tumor/ disease | Multivariate/ univariate cox regression | Clinicopathologic characteristics of patients | References |
---|---|---|---|---|---|---|---|
Acute leukemia | 138 AL patients and 15 healthy controls | Downregulated | [10] | ||||
Bladder cancer | Plasma samples from 50 patients with bladder cancer and 60 normal subjects 20 pairs of tumor tissues and ANTs | Downregulated | High clinical grade | [11] | |||
60 pairs of tumor tissues and ANTs | Upregulation of miR-20a (a target of PTENP1) | [12] | |||||
Breast cancer | 52 pairs of tumor tissues and ANTs | Downregulated | Poorer OS | Advanced BC stages | [13] | ||
65 pairs of tumor tissues and ANTs | Downregulated | [14] | |||||
20 pairs of tumor tissues and ANTs | Downregulated | [16] | |||||
Cervical cancer | 54 pairs of tumor tissues and ANTs | Downregulated | FIGO stage and the lymph node metastasis | [17] | |||
88 pairs of tumor tissues and ANTs | Downregulated | Poorer OS | Advanced stage, FIGO stage, tumor size and lymph node metastasis | [18] | |||
56 pairs of tumor tissues and ANTs | Downregulated | Poorer OS | Advanced FIGO stage, metastasis and recurrence | [19] | |||
Endometrioid endometrial carcinoma | 40 pairs of tumor tissues and ANTs GEO database and TGCA database | Downregulated | [20] | ||||
Esophageal carcinoma | GEO database (GSE20347): 17 pairs of tumor tissues and ANTs | Downregulated | [21] | ||||
93 ESCC patients | Downregulated | Poorer OS | TNM stage and PTENP1 expression were found to be independent factors that influence the OS of patients after radical esophagectomy. | Histological grade, more advanced TNM stage, deep infiltration depth, and lymph node metastasis | |||
Gastric cancer | 768 GC patients and 768 healthy controls | Downregulated | Patients who had rs7853346 G allele showed a remarkably decreased risk of GC in comparison with those carrying C allele. Samples with rs7853346 CG/GG genotype showed high PTENP1 mRNA expression levels than those with CC genotype. | [37] | |||
Gastric cancer | 36 pairs of tumor tissues and ANTs | Downregulated | Tumor size, clinic stage and invasion depth | [22] | |||
Glioma | 23 gliomas tissue samples | Downregulated | [23] | ||||
279 glioma patients | Downregulated | Downregulated in patients carrying the CG&GG genotypes of rs7853346 compared with patients carrying the CC genotype of rs7853346 | [38] | ||||
Head and neck squamous cell carcinoma | 57 HNSCC tissues and 27 ANTs | Downregulated | Poorer OS or DFS | PTENP1 level was found to be an independent predictor of the OS and DFS in patients. | History of alcohol use | [25] | |
Hepatocellular carcinoma | 48 pairs of tumor tissues and ANTs | Downregulated | Poorer OS | Tumor size and TNM stage | [27] | ||
129 patients with HCC, 49 patients with liver cirrhosis, 27 patients with chronic HBV, and 93 normal subjects | Downregulated in HCC than in control groups | [39] | |||||
Multiple myeloma | 43 multiple myeloma patients and 35 healthy controls | Upregulated | Samples with CC genotype showed higher levels of PTENP1 and TSC1 mRNA, and lower level of miR-19b compared to the CG and GG groups. G allele of rs7853346 polymorphism induces the proliferation of cancer stem cells. | [29] | |||
Oral squamous cell carcinoma | 62 pairs of tumor tissues and ANTs | Downregulated | Poorer OS | pT-stage and clinical stage | [30] | ||
342 OSCC patients and 711 healthy controls 20 pairs of tumor tissues and ANTs | rs7853346 strongly reduced OSCC risk. | rs7853346 strongly decreased OSCC risk with gender, age, smoking and drinking condition adjusted. | [40] | ||||
Renal cell carcinoma | 40 pairs of tumor tissues and ANTs | Downregulated | [31] | ||||
Osteoporosis | 30 postmenopausal females with osteoporosis and 15 premenopausal females with arthritis (as controls) | Downregulated | [34] |